Literature DB >> 7891297

Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.

M Yoshioka1, B C Hancock, G Zografi.   

Abstract

The solid state crystallization of amorphous polymers, sugars, and inorganic glasses is often thought to be restricted to the region above the glass transition temperature, Tg, because insufficient molecular mobility (high viscosity) exists below Tg for nucleation and crystal growth. Here we report on the isothermal and nonisothermal crystallization of dry amorphous indomethacin in the temperature range of 20 degrees C above and below its Tg. These studies were carried out with two amorphous samples having different degrees of metastability relative to the crystalline state. It was shown that in both samples significant crystallization to the most stable polymorphic form occurred over several days when stored below Tg, and in some cases this process was preceded by the relaxation of one amorphous form to the other. At storage temperatures near to and above Tg the rates of crystallization increased as expected but a second less thermodynamically stable polymorph also appeared with the more stable crystal form. This behavior was explained by the possible relationship between the degree of metastability relative to the crystalline state of each amorphous form and the interfacial energy existing at the respective nucleation sites, in accord with the Ostwald step rule.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891297     DOI: 10.1002/jps.2600831211

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  72 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Crystallization of mannitol below Tg' during freeze-drying in binary and ternary aqueous systems.

Authors:  Abira Pyne; Rahul Surana; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

3.  Moringa coagulant as a stabilizer for amorphous solids: Part I.

Authors:  Santosh Bhende; Namdeo Jadhav
Journal:  AAPS PharmSciTech       Date:  2012-02-23       Impact factor: 3.246

4.  A practical method to predict physical stability of amorphous solid dispersions.

Authors:  Stéphanie Greco; Jean-René Authelin; Caroline Leveder; Audrey Segalini
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

5.  Effect of compression on non-isothermal crystallization behaviour of amorphous indomethacin.

Authors:  Zelalem Ayenew; Amrit Paudel; Patrick Rombaut; Guy Van den Mooter
Journal:  Pharm Res       Date:  2012-05-26       Impact factor: 4.200

6.  Fast surface crystallization of amorphous griseofulvin below T g.

Authors:  Lei Zhu; Janan Jona; Karthik Nagapudi; Tian Wu
Journal:  Pharm Res       Date:  2010-04-23       Impact factor: 4.200

7.  Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

8.  Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times.

Authors:  Katsuhiko Masuda; Sachio Tabata; Yasuyuki Sakata; Tetsuo Hayase; Etsuo Yonemochi; Katsuhide Terada
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

9.  Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.

Authors:  Danforth P Miller; David Lechuga-Ballesteros
Journal:  Pharm Res       Date:  2006-09-06       Impact factor: 4.200

10.  Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP.

Authors:  Q Lu; G Zografi
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.